Kyoichi Kaira


Ontology type: schema:Person     


Person Info

NAME

Kyoichi

SURNAME

Kaira

Publications in SciGraph latest 50 shown

  • 2018-12 Prognostic value of metabolic tumor volume of pretreatment 18F-FAMT PET/CT in non-small cell lung Cancer in BMC MEDICAL IMAGING
  • 2018-08 Reply to: Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2018-07 Efficacy and safety of cytotoxic drug chemotherapy after first-line EGFR–TKI treatment in elderly patients with non-small-cell lung cancer harboring sensitive EGFR mutations in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2018-04 The effect of post-progression survival on overall survival among patients with sensitive relapse of small cell lung cancer in MEDICAL ONCOLOGY
  • 2018-01 Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2018-01 A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2018-01 Metabolic activity by 18F–FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2017-12 High STMN1 Expression is Associated with Cancer Progression and Chemo-Resistance in Lung Squamous Cell Carcinoma in ANNALS OF SURGICAL ONCOLOGY
  • 2017-10 High expression of GRP78/BiP as a novel predictor of favorable outcomes in patients with advanced thymic carcinoma in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2017-09 A mild phenotype of hand, foot and mouth disease caused by Coxsackievirus A6 in EUROPEAN JOURNAL OF DERMATOLOGY
  • 2017-09 A retrospective study of amrubicin monotherapy for the treatment of relapsed small cell lung cancer in elderly patients in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2017-04 High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients in BRITISH JOURNAL OF CANCER
  • 2017-03 Detection of human papillomavirus type 35 in recurrent Bowen’s disease lesions of the fingers in EUROPEAN JOURNAL OF DERMATOLOGY
  • 2017-03 Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2017-01 Successful afatinib treatment of advanced non-small-cell lung cancer patients undergoing hemodialysis in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2017-01 Phase I study of nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2017-01 Clinical and Pathological Significance of ER Stress Marker (BiP/GRP78 and PERK) Expression in Malignant Melanoma in PATHOLOGY & ONCOLOGY RESEARCH
  • 2017 PET-CT, Bio-imaging for Predicting Prognosis and Response to Chemotherapy in Patients with Lung Cancer in MOLECULAR TARGETED THERAPY OF LUNG CANCER
  • 2016-11 Elemental and immunohistochemical analysis of the lungs and hilar lymph node in a patient with asbestos exposure, a pilot study in ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE
  • 2016-10 Risk factors associated with recurrence of surgically resected node-positive non-small cell lung cancer in SURGERY TODAY
  • 2016-10 Clinical significance of β2-adrenergic receptor expression in patients with surgically resected gastric adenocarcinoma in TUMOR BIOLOGY
  • 2016-09 Relationship between tumor-associated macrophage subsets and CD47 expression in squamous cell carcinoma of the head and neck in the tumor microenvironment in LABORATORY INVESTIGATION
  • 2016-05 Prognostic significance of β2-adrenergic receptor expression in malignant melanoma in TUMOR BIOLOGY
  • 2016-04 Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2015-12 Comparison of platinum combination re-challenge therapy and docetaxel monotherapy in non-small cell lung cancer patients previously treated with platinum-based chemoradiotherapy in SPRINGERPLUS
  • 2015-12 Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer in BMC CANCER
  • 2015-10 First-line gefitinib treatment in elderly patients (aged ≥75 years) with non-small cell lung cancer harboring EGFR mutations in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2015-09 Efficacy of platinum combination chemotherapy after first-line gefitinib treatment in non-small cell lung cancer patients harboring sensitive EGFR mutations in CLINICAL AND TRANSLATIONAL ONCOLOGY
  • 2015-09 Expression of Amino Acid Transporters (LAT1 and ASCT2) in Patients with Stage III/IV Laryngeal Squamous Cell Carcinoma in PATHOLOGY & ONCOLOGY RESEARCH
  • 2015-06 Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer in SUPPORTIVE CARE IN CANCER
  • 2015-06 The efficacy of amrubicin on central nervous system metastases originating from small-cell lung cancer: a case series of eight patients in INVESTIGATIONAL NEW DRUGS
  • 2015-05 An Autosomal Recessive Mutation of DSG4 Causes Monilethrix through the ER Stress Response in JOURNAL OF INVESTIGATIVE DERMATOLOGY
  • 2014-12 Small-cell lung cancer with voltage-gated calcium channel antibody-positive paraneoplastic limbic encephalitis: a case report in JOURNAL OF MEDICAL CASE REPORTS
  • 2014-09 Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma in INFLAMMATION RESEARCH
  • 2014-08 Individual-level data on the relationships of progression-free survival and post-progression survival with overall survival in patients with advanced non-squamous non-small cell lung cancer patients who received second-line chemotherapy in MEDICAL ONCOLOGY
  • 2014-05 Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer in BRITISH JOURNAL OF CANCER
  • 2014-04 Biological significance of fluorine-18-α-methyltyrosine (FAMT) uptake on PET in patients with oesophageal cancer in BRITISH JOURNAL OF CANCER
  • 2014-04 Clinicopathological and prognostic significance of interleukin-8 expression and its relationship to KRAS mutation in lung adenocarcinoma in BRITISH JOURNAL OF CANCER
  • 2014-04 ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer in BRITISH JOURNAL OF CANCER
  • 2013-12 Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer in BMC CANCER
  • 2013-10 Clinicopathological Significance of L-type Amino Acid Transporter 1 (LAT1) Expression in Patients with Adenoid Cystic Carcinoma in PATHOLOGY & ONCOLOGY RESEARCH
  • 2013-10 Diagnostic usefulness of 18F-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2013-08 Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer in ONCOGENE
  • 2013-06 The role of βIII-tubulin in non-small cell lung cancer patients treated by taxane-based chemotherapy in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2013-05 Biological evaluation of 3-[18F]fluoro-α-methyl-d-tyrosine (d-[18F]FAMT) as a novel amino acid tracer for positron emission tomography in ANNALS OF NUCLEAR MEDICINE
  • 2012-12 18F-FAMT in patients with multiple myeloma: clinical utility compared to 18F-FDG in ANNALS OF NUCLEAR MEDICINE
  • 2012-09 Thymidylate synthase expression is closely associated with outcome in patients with pulmonary adenocarcinoma in MEDICAL ONCOLOGY
  • 2012-08 Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer in BRITISH JOURNAL OF CANCER
  • 2012-04 RETRACTED ARTICLE: Relationship between 18F-FDG uptake on PET and various biologic molecular markers in benign pulmonary lesion: comparison with primary lung cancer in ANNALS OF NUCLEAR MEDICINE
  • 2012-04 MUC1 Expression in Pulmonary Metastatic Tumors: A Comparison of Primary Lung Cancer in PATHOLOGY & ONCOLOGY RESEARCH
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.256642.1", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.410802.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.415797.9", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411887.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.416269.e", 
            "type": "Organization"
          }
        ], 
        "familyName": "Kaira", 
        "givenName": "Kyoichi", 
        "id": "sg:person.01360351213.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360351213.71"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:48", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_533.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01360351213.71'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01360351213.71'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01360351213.71'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01360351213.71'


     

    This table displays all metadata directly associated to this object as RDF triples.

    24 TRIPLES      10 PREDICATES      15 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01360351213.71 schema:affiliation Nac1882a098e744df8d2bee6fdd877ec7
    2 https://www.grid.ac/institutes/grid.410802.f
    3 https://www.grid.ac/institutes/grid.411887.3
    4 https://www.grid.ac/institutes/grid.415797.9
    5 https://www.grid.ac/institutes/grid.416269.e
    6 schema:familyName Kaira
    7 schema:givenName Kyoichi
    8 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360351213.71
    9 schema:sdDatePublished 2019-03-07T14:48
    10 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    11 schema:sdPublisher N5e338f230c4944b8b3c96004fd886f00
    12 sgo:license sg:explorer/license/
    13 sgo:sdDataset persons
    14 rdf:type schema:Person
    15 N5e338f230c4944b8b3c96004fd886f00 schema:name Springer Nature - SN SciGraph project
    16 rdf:type schema:Organization
    17 Nac1882a098e744df8d2bee6fdd877ec7 schema:affiliation https://www.grid.ac/institutes/grid.256642.1
    18 sgo:isCurrent true
    19 rdf:type schema:OrganizationRole
    20 https://www.grid.ac/institutes/grid.256642.1 schema:Organization
    21 https://www.grid.ac/institutes/grid.410802.f schema:Organization
    22 https://www.grid.ac/institutes/grid.411887.3 schema:Organization
    23 https://www.grid.ac/institutes/grid.415797.9 schema:Organization
    24 https://www.grid.ac/institutes/grid.416269.e schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...